These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22576193)

  • 1. Speeding discoveries with neoadjuvant studies.
    Cancer Discov; 2012 Apr; 2(4):294. PubMed ID: 22576193
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting locoregional recurrence after neoadjuvant chemotherapy in patients with breast cancer.
    Mamounas TP
    Clin Adv Hematol Oncol; 2013 Mar; 11(3):175-7. PubMed ID: 23598985
    [No Abstract]   [Full Text] [Related]  

  • 3. Q&A: Eric Winer on neoadjuvant clinical trials.
    Winer E
    Cancer Discov; 2013 Aug; 3(8):832. PubMed ID: 23928759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
    Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G
    J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant endocrine therapy for breast cancer: more questions than answers.
    Ellis MJ
    J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901
    [No Abstract]   [Full Text] [Related]  

  • 6. A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.
    Connolly R; Stearns V
    Oncology (Williston Park); 2010 Feb; 24(2):135-43. PubMed ID: 20361464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [So that survival chances in breast cancer are improved. Finding a "clinical trial opportunity" for your patients].
    Vetter C
    MMW Fortschr Med; 2003 Apr; 145(16):14. PubMed ID: 14606393
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.
    Alvarez RH; Hortobagyi GN
    Breast Cancer Res Treat; 2010 Dec; 124(3):701-5. PubMed ID: 20953832
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
    Wynendaele W; van Oosterom AT
    Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant endocrine therapy in breast cancer.
    Beresford MJ; Ravichandran D; Makris A
    Cancer Treat Rev; 2007 Feb; 33(1):48-57. PubMed ID: 17134840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapies in breast cancer.
    Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario].
    Solá M; Fraile M
    Rev Esp Med Nucl; 2010; 29(6):316-8. PubMed ID: 21055516
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant endocrine therapy for breast cancer: medical perspectives.
    Ellis MJ
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?
    von Minckwitz G; Fontanella C
    Breast; 2013 Aug; 22 Suppl 2():S149-51. PubMed ID: 24074777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based neoadjuvant endocrine therapy for breast cancer.
    Dienstmann R; Bines J
    Clin Breast Cancer; 2006 Oct; 7(4):315-20. PubMed ID: 17092398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemotherapy for breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):212, 215. PubMed ID: 16163183
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for operable breast cancer.
    Green M; Hortobagyi GN
    Oncology (Williston Park); 2002 Jul; 16(7):871-84, 889; discussion 889-90, 892-4, 897-8. PubMed ID: 12164555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast carcinoma. Preoperative chemotherapy can preserve the breast].
    MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534003
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant therapy as a platform for drug development and approval in breast cancer.
    Bardia A; Baselga J
    Clin Cancer Res; 2013 Dec; 19(23):6360-70. PubMed ID: 24298066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of early breast cancer. IV: neoadjuvant treatment.
    Smith I; Chua S
    BMJ; 2006 Jan; 332(7535):223-4. PubMed ID: 16439402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.